Chapter 12: Biochemical Signaling Flashcards
In multicellular organisms, what is the largest group of plasma membrane receptors?
GPCRs
Signal transduction is the conversion of information into a _______ change
chemical change
Receptors are found on the _____ side of the membrane
extra-cellular
What is a receptor?
A membrane bound or soluble protein which causes a physiological effect after binding its ligand
Four common receptor types
G-protein coupled receptors (epinephrine)
Enzyme-linked receptors (insulin)
Ligand-gated ion channels (nicotinic acetylcholine)
Nuclear receptors (steroids)
Types of ligands for receptors
- Small ions (ferric ion)
- organic molecules (NTs like adrenaline)
- Polysacchardies (heparin)
- Peptides (insulin)
- proteins (vascular endothelial growth factor)
Explain Signal Transduction Specificity
A signaling ligand fits to the binding site of its complementary ligand - molecular complementarity exists b/w the signal and receptor… only binds what its looking for and nothing else
- results from high affinity of receptors for their ligands
- mediated by noncovalent forces
What is signal transduction amplification?
When an enzyme activates other enzymes, the number of molecules affected increases in a cascading manner
What are scaffold proteins ?
Non-enzymatic proteins that bring together enzymes within a cascade
- don’t do anything besides putting things where they need to be
What does signal transduction MODULARITY refer to?
modular means the receptor recognizes multiple
What is signal transduction?
The conversion of information into a chemical change
What happens when a receptor becomes desensitized?
Desensitization occurs when a signal is continuously present and the receptor system no longer responds to the signal
What is integration?
The ability of a receptor system to receive multiple signals and in turn produce a unified response
What does it mean for signaling pathways to be divergent?
Divergent means they are branched rather than linear
What is response localization?
When the components of a signaling system are confined to a specific subcellular structure (a raft in the plasma membrane, for example), a cell can regulate a process locally, without affecting distant regions of the cell.
Characteristics of GPCRs
GPCRs = Guanosine nucleotide-binding protein
- alpha helical integral membrane proteins
- heterotrimeric (alpha, beta, gamma)
- G-proteins mediate signal transduction from GPCRs to other target proteins
example of GPCR: B-adrenergic receptor system
Gated ion channels
open and close in response to the binding of chemical ligands or changes in transmembrane potential. The simplest signal transducers
Enzyme-linked receptors
enzymatic activity occurs on the cytoplasmic side, triggered by ligand binding on the extracellular side
-ex: tyroisne kinase which catalyze the phosphorylation of Tyr residues
Agonist vs Antagonist
Agonist - binds receptor to mimic response of ligand , are molecules (natural ligands or their structural analogs) that bind a receptor and produce the effects of the natural ligand
Antagonist- binds receptor but causes no response, thereby blocking the effects of agonists
Components of the GPCR
- a plasma membrane receptor with seven transmembrane helical segments
- a G protein that cycles between active (guanosine triphosphate (GTP)-bound) and inactive (guanosine diphosphate (GDP)-bound) forms
-an effector enzyme (or ion channel) in the plasma membrane that is regulated by the activated G protein
-An extracellular signal such as a hormone, growth factor, or neurotransmitter is the “first messenger” that activates a receptor from outside the cell
When are GPCRs active?
when GTP bound
When are GPCRs inactive?
when GDP bound and therefore in the trimeric form
What subunit contains the binding site for GDP/GTP on the GPCR?
the alphs subunit
What is the first messenger in GPCR
First messenger = some extracellular signal that activates a receptor from outside. the cell
What is a second messenger in GPCR pathway?
second messengers are usually CAMP, diacylglycerol, IP3, or Ca2+ which either inhibit or activate one or more downstream targets, usually protein kinases